{"schema_version":"secwatch.filing_event.v1","accession":"0001193125-22-168821","form_type":"8-K","ticker":"RGNX","cik":"0001590877","company_name":"REGENXBIO Inc.","filed_at":"2022-06-07T23:59:59+00:00","discovered_at":"2026-05-14T18:04:01.347594+00:00","generated_at":"2026-06-25T03:56:39.800970+00:00","sec_items":["5.02","5.07","9.01"],"event_type":"leadership","sentiment":"neutral","materiality_score":0.35,"calibrated_materiality_score":0.35,"confidence":"high","headline":"REGENXBIO appoints Jennifer Zachary to board; annual meeting results ratified","bullets":["Jennifer Zachary elected Class I director and Audit Committee member, effective June 3, 2022.","Ms. Zachary receives initial equity award of $550,000 (75% option, 25% RSUs) at $22.84 exercise price.","Annual meeting re-elected Allan Fox and Alexandra Glucksmann as Class I directors; PwC ratified as auditor.","Advisory vote on named executive officer compensation approved with 96% of votes cast in favor.","Ms. Zachary is EVP & General Counsel of Merck, bringing 20+ years of pharma and regulatory experience."],"urls":{"canonical":"https://secwatch.observer/filing/0001193125-22-168821","json":"https://secwatch.observer/filing/0001193125-22-168821.json","markdown":"https://secwatch.observer/filing/0001193125-22-168821.md","text":"https://secwatch.observer/filing/0001193125-22-168821.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1590877/000119312522168821/0001193125-22-168821-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1590877/000119312522168821/d345163d8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-25T03:56:39.800970+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"ef62505298","claim":"Jennifer Zachary was elected as Class I Director at REGENXBIO Inc..","evidence_excerpt":"elected Jennifer Zachary as a Class I director of the Company and a member of the Audit Committee, effective immediately.","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1590877/000119312522168821/0001193125-22-168821-index.htm","confidence":0.95,"family_label":"Executive change","details":[{"label":"Action","value":"elected"},{"label":"Role","value":"Class I Director"}],"fact_type":"executive_change"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}